Mechanism of anti-lipolytic action of acipimox in isolated rat adipocytes

Diabetologia

Volumn 39, Issue 1, 1996, Pages 45-53

  Christie, A W ^a   McCormick, D K T ^a   Emmison, N ^a   Kraemer, F B ^b   Alberti, K G M M ^a   Yeaman, S J ^a,c  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Acipimox; Adipocytes; Cyclic AMP; Cyclic AMP dependent protein kinase; Enzyme translocation; Hormone sensitive lipase; Insulin; Lipolysis

Indexed keywords

ACIPIMOX; ADENOSINE DEAMINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; INSULIN; ISOPRENALINE; TRIACYLGLYCEROL LIPASE;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MECHANISM; HYPERTRIGLYCERIDEMIA; IMMUNOBLOTTING; LIPOLYSIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE DEAMINASE; ADIPOCYTES; ANIMALS; ANTILIPEMIC AGENTS; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GLYCEROL; ISOPROTERENOL; KINETICS; LIPASE; LIPOLYSIS; MALE; PYRAZINES; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS;

EID: 0030031015     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Howard BV (1987) Lipoprotein metabolism in diabetes mellitus. J Lipid Res 28: 613-628
2. Study Group, European Atherosclerosis Society (1988) The regulation and management of hyperlipidaemia in adults: a policy statement of the European Atherosclerosis Society. Eur Heart Journal 9: 571-600
3. Tornvall P, Walldius GW (1991) A comparison between nicotinic acid and acipimox in hypertriglyceridaemia - effects on serum lipids, lipoproteins, glucose tolerance and tolerability. J Int Med 230: 415-421
4. Sirtori CR, Gianfranceschi G, Sirtori M et al. (1981) Reduced triglyceridaemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, a new inhibitor of lipolysis. Atherosclerosis 38: 267-271
5. Stuyt PMJ, Stalenhoef AFH, Demacker PNM, Van't Laar A (1985) A comparative study of the effects of acipimox and clofibrate in type III and type IV hyperlipoproteinaemia. Atherosclerosis 55: 51-62
6. Ball MJ, Vella M, Reckless JPD et al. (1986) Acipimox in the treatment of patients with hyperlipidaemia: a double blind trial. Eur J Clin Pharmacol 31: 201-204
7. Crepaldi G, Avogaro P, Descovich GC et al. (1988) Plasma lipid lowering activity of acipimox in patients with type II and type IV hyperlipoproteinaemia: Results of a multicentre trial. Atherosclerosis 70: 115-121
8. Lovisolo PP, Briatco-Vangosa G, Orsini G, Ronchi R, Angelucci R, Valzelli G (1981) Pharmacological profile of a new anti-lipolytic agent: 5-methyl-pyrazine-2-carboxylic acid 4-oxide (acipimox) I. Mechanism of action. Pharmacological Res Comm 13: 151-161
9. Stirling C, McAleer M, Reckless JPD et al. (1985) Effects of acipimox, a nicotinic acid derivative, on lipolysis in human adipose tissue and on cholesterol synthesis in human jejunal mucosa. Clin Sci 68: 83-88
10. Reaven GM, Hollenbeck C, Jeng C-Y, Wu MS, Chen Y-D I (1988) Measurement of plasma free fatty acid, lactate and insulin for 24 h in patients with NIDDM. Diabetes 37: 1020-1024
11. Randle PJ, Garland PB, Hales CN, Newsholme EA (1963) The glucose fatty-acid cycle: its role in insulin sensitivity and the metabolic disturbances in diabetes mellitus. Lancet I:785-789
12. Fulcher GR, Walker M, Catalano C, Agius L, Alberti KGMM (1992) Metabolic effects of suppression of non-esterified fatty acid levels with acipimox in obese NIDDM subjects. Diabetes 41: 1400-1408
13. Yeaman SJ (1990) Hormone-sensitive lipase - a multipurpose enzyme in lipid metabolism. Biochim Biophys Acta 1052: 128-132
14. Fain JN, Malbon CC (1979) Regulation of adenylate cyclasc by adenosine. Mol Cell Biochem 25: 143-169
15. Moreno FJ, Shepherd RE, Fain JN (1979) Effect of NAD, nicotinamide and nicotinic acid on cyclic AMP accumulation by fat cells. Naunyn-Schmiedebergs Arch Pharmacol 306: 179-183
16. 2 on human fat cell adenylate cyclase. J Clin Invest 64: 609-612
17. Fain JN (1980) Hormonal regulation of lipid mobilization from adipose tissue. Biochem Actions Hormones VII:119-204
18. Stralfors P, Bjorgell P, Belfrage P (1984) Hormonal regulation of hormone-sensitive lipase in intact adipocytes - identification of phosphorylated sites and effects on the phosphorylation by lipolytic hormones and insulin. Proc Natl Acad Sci USA 81: 3317-3321
19. Smith CJ, Vasta V, Degerman E, Belfrage P, Manganiello VC (1991) Hormone-sensitive cyclic GMP-inhibited cyclic AMP phosphodiesterase in rat adipocytes. J Biol Chem 266: 13385-13390
20. Illiano G, Cuatrecasas F (1972) Modulation of adenylate cyclase activity in liver and fat cell membranes by insulin. Science 175: 906-908
21. Londos C, Honnor RC, Dhillon GS (1985) cAMP-dependent protein kinase and lipolysis in rat adipocytes. III. Multiple modes of insulin regulation of lipolysis and regulation of insulin responses by adenylate cyclase regulators. J Biol Chem 260: 15139-15145
22. Egan JJ, Greenberg AS, Chang M-K, Wek SA, Moos Jr MC, Londos C (1992) Mechanism of hormone-stimulated lipolysis in adipocyles: translocation of hormone-sensitive lipase to the lipid storage droplet. Proc Natl Acad Sci USA 89: 8537-8541
23. Cheng H-C, Kemp BE, Pearson RB et al. (1986) A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. J Biol Chem 261: 989-992
24. Kraemer FB, Patel S, Saedi MS, Sztalryd C (1993) Detection of hormone-sensitive lipase in various tissues I. Expression of an HSL/bacterial fusion protein and generation of anti-HSL antibodies. J Lipid Res 34: 663-671
25. Kather H, Wieland E ( 1984) Glycerol. Luminometric method. In: Bergmeyer HU (ed) Methods of enzymatic analysis, Vol 6. Verlag Chemie Weinheim, Germany, pp 510-518
26. Gilman AG (1970) A protein binding assay for adenosine 3′,5′-cyclic monophosphate. Proc Natl Acad Sci USA 67: 305-312
27. Laemelli UK, Favre M (1973) Maturation of the head of bacteriophage T4. J Mol Biol 80: 575-599
28. Hales CN, Luzio JP, Siddle K (1978) Hormonal control of adipose tissue lipolysis. Biochem Soc Symp 43: 97-135
29. Sengupta K, Long KJ, Allen DO (1981) Relationship among isoproterenol, cyclic AMP, cyclic AMP-dependent protein kinase and lipolysis in perfused fat cells. J Pharmacol Exp Ther 218: 128-133
30. Litosch I, Hudson H, Mills I, Li S-Y, Fain JN (1982) Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes. Mol Pharmacol 22: 109-115
31. Fain JN, Wieser PB (1975) Effects of adenosine deaminase on cyclic adenosine monophosphate accumulation, lipolysis, and glucose metabolism in fat cells. J Biol Chem 250; 1027-1034
32. Aitchison RED, Clegg RA, Vernon RG (1982) Lipolysis in rat adipocytes during pregnancy and lactation. Biochem J 202: 243-247
33. Saggerson ED (1986) Sensitivity of adipocyte lipolysis to stimulatory and inhibitory agonists in hypothyroidism and starvation. Biochem J 238: 387-394
34. 1, phenylisopropyl-adenosine and nicotinic acid as regulators of fat cell metabolism. Endocrinology 96: 1221-1225
35. + amplifies adenosine receptor-mediated inhibition of adipocyte adenylate cyclase. Eur J Pharmacol 71: 157-160
36. Olansky L, Myers GA, Pohl SL, Hewlett EL (1983) Promotion of lipolysis in rat adipocytes by pertussis toxin: reversal of endogenous inhibition. Proc Natl Acad Sci USA 80; 6547-6551
37. Aktories K, Jakobs KH, Schultz G (1980) Nicotinic acid inhibits adipocyte adenylate cyclase in a hormone-like manner. FEBS Letts 115:11-14
38. Aktories K, Schultz G, Jakobs KH (1980) Regulation of adenylate cyclase in hamster adipocytes. Inhibition by prostaglandins, α-adrenergic agonists and nicotinic acid. Naunyn-Schmiedebergs Arch Pharmacol 312: 167-173
39. Kather H, Aktories K, Schultz G, Jakobs KH (1983) Islet-activating protein discriminates the antilipolytic mechanism of insulin from that of other antilipolytic compounds. FEBS Letts 161: 149-152
40. Londos C, Cooper DMF, Rodbell M (1981) Receptor-mediated stimulation and inhibition of adenylate cyclases: the fat cell as a model system. In: Dumont JE, Greengard P, Rohison GA (eds) Advances in cyclic nucleotide research, vol 14. Raven Press, New York, pp 163-167
41. Greenberg AS, Egan JJ, Wek SA, Garty NB, Blanchette-Mackie EJ, Londos C (1991) Perilipin, a major hormonally regulated adipocyte-specific phosphoprotein associated with the periphery of lipid storage droplets. J Biol Chem 266: 11341-11346
42. Stralfors P, Honnor RC (1989) Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity. Eur J Biochem 182: 379-385
43. Egan JJ, Greenberg AS, Chang M-K, Londos C (1990) Control of endogenous phosphorylation of the major cAMP-dependent protein kinase substrate in adipocytes by insulin and β-adrenergic stimulation. J Biol Chem 265: 18769-18775
44. Musatti L, Maggi E, Moro E, Valzelli G, Tamassia V (1981) Bioavailability and pharmacokinetics in man of acipimox, a new antilipolytic and hypolipemic agent. J Int Med Res 9: 381-386